[Author(id=1331399778680778926, tenantId=1045748351789510663, journalId=null, articleId=1179743365073560431, orderNo=null, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=null, email=null, emailSecond=null, emailThird=null, correspondingAuthor=null, authorType=null, ext={CN=AuthorExt(id=null, tenantId=null, journalId=1179462044320763939, articleId=1179743365073560431, authorId=1331399778680778926, language=CN, stringName=刘海滨, 吴旭东, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=null, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=null)]
刘海滨, 吴旭东.
乳腺癌患者新辅助化疗前后血浆FIB、DD水平和CD4+、CD4+/CD8+变化与预后的相关性分析[J].
川北医学院学报, 2023, 38(04): 542-546 DOI:CNKI:SUN:NOTH.0.2023-04-025